Jörg Tomeczkowski | Director, HTA Strategy
Institute for Evidence-Based Positioning in Healthcare

Jörg Tomeczkowski is a seasoned professional with a wealth of experience in healthcare pricing, access, and evidence-based positioning. As the Director of HTA Strategy at the Institute for Evidence-Based Positioning in Healthcare, Jörg brings a unique blend of expertise in health technology assessment (HTA) and strategic planning. With a proven track record of developing successful pricing and access strategies for healthcare products, Jörg is at the forefront of shaping the future of healthcare market access.

Throughout his career, Jörg has demonstrated a deep understanding of the complexities of the healthcare landscape, working with stakeholders across the industry to drive evidence-based decision-making. His strategic insights and innovative approach have helped organizations navigate the evolving healthcare environment, ensuring optimal market access and reimbursement for their products.

Jörg is a thought leader in the field of healthcare pricing and access, regularly sharing his expertise at industry conferences and events. His upcoming speaking engagement at the World EPA Congress 2026, Europe’s Leading Healthcare Pricing, Access, and Evidence Congress, is a testament to his reputation as a trusted authority in the industry.

With a passion for driving positive change in healthcare, Jörg is dedicated to advancing evidence-based positioning strategies that improve patient access to innovative treatments. His commitment to excellence and his ability to deliver results make him a valuable asset to any organization looking to succeed in today’s competitive healthcare market.